Gunst, J., Gohil, J., Li, J., Bosch, R., White, A., Seamon, C., Chun, T.-W., Mothe, B., Gittens, K., Praiss, L., De Scheerder, M.-A., Vandekerckhove, L., Escandón, K., thorkelson, A., Schacker, T., SenGupta, D., Brander, C., Papasavvas, E., Montaner, L.J., Martinez-Picado, J., Calin, R., Castagna, A., Muccini, C., Jong, W., Leal, L., Garcia, F., Gruters, R., Tipoe, T., Frater, J., Sogaard O., Fidler, S. Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: An individual data-based meta-analysis of 24 prospective studies , Nature Communications: 2025

Moskovjevic, M., Dragoni, F., Board, N.L., Wu, F., Lai, J., Zhang, H., White, J., Hoh, R., Lynn, K., Tebas, P., Mounzer, K., Deeks, S.G., Montaner, L.J., Siliciano, J.D., Siliciano, R.F., Simonetti, F.R. Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy , Immunity: 2024

Emade Nkwelle, C., Babiaka, S.B., Metuge, C.S., Liang, K., Stephens, U., Esemu, S.N., Zuzga, D.S., Shuda McGuire, K., Montaner, L.J., Ndip, R.N., Tietjen, I., Ntie-Kang, F. Croton oligandrus Pierre & Hutch (Euphorbiaceae) Extracts and Isolated Compounds Reverse HIV-1 Latency , Journal of Experimental Pharmacology: 2024

Meanley, S., Carter, W., Short, W.B., Metzger, D.S., Onorato, A., Montaner, L.J., Dubé, K. HIV Clinical Providers' Awareness, Attitudes, and Willingness to Support Patient Outreach Efforts for HIV Cure-Directed Research in Philadelphia, United States , Open Forum Infectious Diseases: 2024

Poli, A.N.R., Tietjen, I., Nandwana, N.K., Cassel, J., Messick, T.E., Register, E.T., Keeney, F., Rajaiah, R., Verma, A.K., Pandey, K., Acharya, A., Byrareddy, S.N., Montaner, L.J., Salvino, J.M. Design of novel and highly selective SARS-CoV-2 main protease inhibitors. , Antimicrobial Agents and Chemotherapy: 2024

Rajaiah, R., Pandey, K., Achrya, A., Ambikan, A., Kumar, N., Guda, R., Avedissian, S.N., Montaner, L.J., Cohen, S.M., Neogi, U., Byareddy, S.N. Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden Syrian hamsters , iScience: 2024

Namba-Nzanguim, C.T., Simoben, C.V., Bekono, B.D., Tietjen, I., Cassel, J., Salvino, J.M., Montaner, L.J., Davis, R.A., Ntie-Kang, F. Investigation of some plant stilbenoids and their fragments for the identification of inhibitors of SARS-CoV2 viral spike/ACE2 protein binding , The Microbe: 2024

Matos-Hernández, M., Samples, R., Dyer, G., Casimir Montan, V., Morales-Colón, C., Salvino, J., Montaner, L.J., Cassel, J., Messick, T., Tietjen, I., Caro-Diaz, E. Metabolomic Analysis and Antiviral Screening of a Marine Algae Library Yield Jobosic Acid (2,5-Dimethyltetradecanoic Acid) as a Selective Inhibitor of SARS-CoV-2 , Journal of Natural Products: 2024

Shayo, M.J., Samwel, B., Shadrack, D.M., Cassel, J., Salvino, J.M., Montaner, L.J., Deogratias, G., Tietjen, I., Kiruri, L., Hilonga, S., Innocent, E. Drug repositioning identifies salvinorin A and deacetylgedunin (DCG) enriched plant extracts as novel inhibitors of Mpro, RBD-ACE2 and TMPRRS2 proteins , RSC Advances: 2024

Shellenberger, B.M., Basile, O.N., Cassel, J., Olsen, M.R., Salvino, J.M., Montaner, L.J., Tietjen, I., Henry, G.E. Synthesis, SARS-CoV-2 main protease inhibition, molecular docking and in silico ADME studies of furanochromene-quinoline hydrazone derivatives , Bioorganic & Medicinal Chemistry Letters: 2024